# NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer

> **NCT02425072** · PHASE2 · WITHDRAWN · sponsor: **John Villano**

## Conditions studied

- Small Cell Lung Cancer
- Brain Metastasis

## Interventions

- **DEVICE:** NovoTTF-100A plus chemotherapy

## Key facts

- **NCT ID:** NCT02425072
- **Lead sponsor:** John Villano
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-04
- **Primary completion:** 2021-07
- **Final completion:** 2022-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** slow accrual
- **Last updated:** 2017-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02425072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02425072, "NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02425072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*